publicli
fund
repositori
covid
databas
right
unrestrict
research
reus
analys
form
mean
acknowledg
origin
sourc
permiss
grant
free
elsevi
long
resourc
centr
remain
activ
microbiolog
respiratori
system
infect
http
dx
coronavirus
cov
group
virus
known
caus
mild
sever
diseas
human
known
human
coronavirus
caus
diseas
belong
genera
alphacoronaviru
betacoronaviru
virus
usual
caus
mild
upper
respiratori
tract
diseas
human
middl
east
respiratori
syndrom
coronaviru
merscov
belong
betacoronavirus
first
identifi
kingdom
saudi
arabia
viru
isol
sputum
man
present
commun
acquir
pneumonia
subsequ
develop
fatal
diseas
associ
acut
renal
failur
respiratori
failur
sinc
apr
date
viru
caus
total
case
includ
death
report
world
health
organ
countri
major
case
occur
arabian
peninsula
case
link
geograph
area
usual
travel
diseas
wide
rang
clinic
present
epidemiolog
clinic
spectrum
rang
mild
diseas
rapidli
fatal
diseas
presenc
asymptomat
case
also
describ
three
main
factor
contribut
transmiss
merscov
viru
host
environ
case
occur
sporad
patient
limit
intrafamili
transmiss
cluster
healthcar
associ
transmiss
sporad
case
may
result
camel
human
transmiss
subsequ
case
secondari
case
among
human
contact
viru
seem
peculiar
tendenc
caus
healthcareassoci
transmiss
exemplifi
multipl
hospit
outbreak
discuss
later
emerg
merscov
caus
great
attent
emerg
respiratori
pathogen
potenti
global
spread
diseas
current
spread
global
understand
pathogen
mode
transmiss
spectrum
diseas
allow
develop
prevent
measur
applic
effect
infect
control
practic
prospect
develop
novel
therapi
use
previou
therapi
treatment
merscov
would
enhanc
abil
combat
diseas
review
epidemiolog
diseas
clinic
present
outcom
coronavirus
part
nidoviral
order
name
stem
presenc
crownlik
spike
surfac
coronavirus
first
identifi
human
pathogen
coronavirus
envelop
rna
virus
four
viru
cluster
within
coronavirina
subfamili
alpha
beta
gamma
delta
coronavirus
pathogen
human
coronavirus
classifi
genera
alphacoronaviru
betacoronaviru
sarscov
merscov
emerg
signific
pathogen
initi
identif
patient
rapidli
fatal
commun
acquir
pneumonia
first
human
coronaviru
lineag
c
betacoronaviru
genu
merscov
viru
known
multipl
clade
circul
human
one
studi
four
differ
phylogenet
merscov
clade
circul
saudi
arabia
sep
may
one
clade
persist
end
observ
period
length
clade
differ
alhasa
clade
apr
case
jeddah
outbreak
belong
singl
clade
indic
humantohuman
transmiss
import
case
south
korea
show
merscov
recombin
group
element
recombin
event
occur
second
half
sinc
apr
oct
total
case
includ
death
report
world
health
organ
countri
case
report
saudi
arabia
tabl
multipl
healthcar
associ
infect
occur
within
saudi
arabia
contribut
signific
increas
number
case
studi
outbreak
occur
alhasa
jeddah
riyadh
alhasa
outbreak
occur
apr
involv
confirm
case
probabl
case
merscov
hospit
marapr
larg
number
case
report
saudi
arabia
unit
arab
emir
jeddah
outbreak
total
hospit
involv
total
case
largest
outbreak
outsid
arabian
peninsula
occur
republ
korea
initi
index
patient
return
trip
multipl
countri
middl
east
bahrainsaudi
arabiauaeqatar
week
outbreak
involv
health
care
facil
case
subsequ
outbreak
republ
korea
involv
health
care
facil
health
care
facil
nosocomi
transmiss
total
number
case
jun
case
death
clinic
present
merscov
vari
asymptomat
mildli
symptomat
case
sever
often
fatal
diseas
larg
number
patient
underli
medic
comorbid
comorbid
includ
diabet
mellitu
cardiac
diseas
renal
failur
hemodialysi
hypertens
tabl
accord
saudi
ministri
health
case
primari
healthcareassoci
infect
household
infect
number
summar
three
epidemiolog
pattern
diseas
sporad
case
occur
commun
probabl
anim
contact
human
human
transmiss
result
healthcareassoci
infect
intrafamili
transmiss
merscov
affect
patient
adult
mean
age
year
rang
year
number
pediatr
case
describ
studi
combin
nasal
throat
swab
yield
merscov
pcr
children
year
age
jordan
rel
low
number
merscov
children
readili
explain
although
initi
merscov
case
sever
requir
intens
care
unit
servic
subsequ
case
includ
less
sever
diseas
proport
asymptomat
case
vari
initi
phase
clinic
ill
nonspecif
includ
fever
mild
nonproduct
cough
last
sever
day
progress
pneumonia
follow
multiorgan
failur
may
result
death
case
fatal
rate
patient
present
fever
cough
short
breath
tabl
patient
may
gastrointestin
symptom
diarrhea
vomit
total
case
medic
comorbid
diabet
chronic
renal
diseas
acut
renal
failur
develop
proport
patient
three
patient
develop
neurolog
sign
alter
level
conscious
confus
coma
ataxia
focal
motor
deficit
mani
nonspecif
laboratori
abnorm
exist
patient
merscov
includ
leucopenia
lymphopenia
thrombocytopenia
increas
lactat
dehydrogenas
ldh
increas
hepat
transaminas
chest
radiograph
abnorm
includ
increas
bronchovascular
mark
unilater
infiltr
bilater
infiltr
diffus
reticulonodular
pattern
studi
show
groundglass
opac
consolid
one
studi
util
ctscan
imag
lower
lobe
commonli
involv
upper
middl
lobe
combin
fatal
case
mean
number
lung
segment
involv
segment
compar
segment
surviv
laboratori
diagnosi
reli
respiratori
tract
sampl
detect
merscov
use
realtim
revers
transcriptas
polymerasechainreact
rtpcr
viru
may
detect
lower
upper
respiratori
tract
sampl
lower
respiratori
tract
sampl
yield
better
diagnost
result
higher
viral
load
lower
respiratori
tract
sampl
highest
viral
load
mean
copiesml
compar
upper
respiratori
tract
sampl
copiesml
urin
copiesml
stool
copiesml
serum
copiesml
serolog
test
use
diagnosi
merscov
data
sensit
specif
antibodi
test
merscov
limit
one
studi
use
plaqu
reduct
neutral
test
prnt
microneutralis
mn
mersspik
pseudoparticl
neutral
ppnt
mer
immunosorb
assay
elisa
found
sensit
specif
main
therapeut
option
merscov
infect
known
vitro
merscov
sensit
alpha
interferon
random
control
trial
exist
establish
efficaci
side
effect
therapeut
modal
learn
sar
experi
interferon
ribavirin
suggest
therapi
merscov
combin
ribavirin
prevent
pneumonia
anim
first
report
use
ribavirin
interferon
show
surviv
advantag
combin
start
late
cours
diseas
surviv
advantag
document
combin
surviv
advantag
day
differ
therapi
ribavirin
ribavirin
treat
merscov
case
report
greec
pegyl
interferon
ribavirin
lopinavirritonavir
initi
day
ill
merscov
detect
respiratori
tract
secret
patient
week
onset
ill
viraemia
last
day
initi
therapi
prospect
control
prevent
merscov
reli
identif
definit
host
interrupt
anim
human
transmiss
applic
proper
infect
control
measur
healthcar
set
avail
data
link
dromedari
camel
human
case
merscov
high
preval
merscov
antibodi
detect
dromedari
camel
across
arabian
peninsula
north
africa
eastern
africa
addit
viral
merscov
detect
sampl
dromedari
camel
multipl
locat
arabian
peninsula
use
rtpcr
main
infect
control
measur
healthcar
set
includ
contact
isol
droplet
isol
airborn
infect
isol
precaut
especi
aerosol
gener
procedur
center
diseas
control
prevent
cdc
recommend
place
patient
suspect
confirm
merscov
infect
airborn
infect
isol
room
aiir
merscov
infect
emerg
infecti
diseas
high
mortal
rate
exact
incid
preval
diseas
evalu
larg
popul
base
survey
use
serolog
kingdom
saudi
arabia
studi
show
antimerscov
antibodi
present
peopl
mean
age
seroposit
individu
significantli
younger
patient
report
laboratoryconfirm
primari
mer
year
vs
year
men
higher
antibodi
preval
women
vs
two
antibodi
preval
significantli
higher
central
versu
coastal
provinc
vs
one
diagnosi
merscov
infect
reli
detect
viru
use
realtim
rtpcr
current
best
therapeut
option
merscov
known
avail
vaccin
